Abbott unit prevails in dispute over catheter patent
25-03-2021
Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute
05-11-2020
pichetw / Shutterstock.com
Healthcare company Abbott Laboratories has agreed to divest two medical device businesses in a bid to settle competition charges brought by the US Federal Trade Commission (FTC).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Abbott Laboratories, St Jude Medical, Mergers & Acquisitions, FTC, Federal Trade Commission, anticompetitive, divest, medical devices
